Author:
Avila Marcel Y,Igua Angela M,Mora Amparo M
Abstract
BackgroundTo evaluate the effectiveness of platelet-rich plasma (PRP) injections in the treatment of severe dry eye.MethodsThis prospective, intervention study included patients with severe dry eye who had been diagnosed with Sjogren syndrome. Patients were divided into two groups. The intervention group received PRP (n=15) injections on days 0, 30, 60 and 90, as well as hyaluronic acid five times per day. The comparison group received hyaluronic acid (n=15) five times per day. Subjects were measured at baseline and at 30, 60 and 90 days. The primary outcome measures were changes in corneal staining according to the Oxford classification, results of the Schirmer test and tear break-up time (TBUT). The secondary outcome measures were changes in the Ocular Surface Disease Index (OSDI) and treatment compliance.ResultsAll subjects completed the study. The intervention group showed improvements in all primary outcome measures when compared with the control group, including a reduction in corneal staining (p<0.001), increase in the mean Schirmer value from 5.6±0.7 to 9.0±1.1 mm, and an increase in TBUT from 4.0±0.4 to 6.4±0.4 s at day 90. An improvement in subjective OSDI values was also found.ConclusionPRP injection is safe and effective in improving tear parameters as well as subjective parameters, and was found to be superior to hyaluronic acid alone in the management of patients with severe dry eye. This represent a novel alternative treatment for severe dry eye.Trial registration numberNCT02257957.
Funder
Universidad Nacional de Colombia
Subject
Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology
Reference18 articles.
1. TFOS DEWS II Management and Therapy Report
2. Development of causative treatment strategies for lacrimal gland insufficiency by tissue engineering and cell therapy;Dietrich;Part 1: Regeneration of lacrimal gland tissue: Can we stimulate lacrimal gland renewal in vivo? Curr Eye Res,2016
3. Eye platelet-rich plasma in the treatment of ocular surface disorders;Alio;Curr Opin Ophthalmol,2015
4. Platelet-rich plasma as treatment for persistent ocular epithelial defects;Ronci;Transfus Apher Sci,2015
5. Platelet-rich plasma prolongs myofibroblast accumulation in corneal stroma with incisional wound;Koulikovska;Curr Eye Res,2015
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献